Literature DB >> 2693102

[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies.

J M Hoffman1, B H Guze, L R Baxter, J C Mazziotta, M E Phelps.   

Abstract

Alzheimer's disease (AD) is becoming an increasingly important public health problem. The clinical diagnosis of AD continues to be problematic and costly. [18F]-fluorodeoxyglucose-position emission tomography (FDG-PET) can assist with the diagnosis of AD at an early stage. The utility of FDG-PET in AD may also be extremely useful in the future when objective physiologic monitoring of drug effects and therapy are required.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2693102     DOI： 10.1159/000116476

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


  6 in total

1.  Association of hypometabolism and amyloid levels in aging, normal subjects.

Authors:  Val J Lowe; Stephen D Weigand; Matthew L Senjem; Prashanthi Vemuri; Lennon Jordan; Kejal Kantarci; Bradley Boeve; Clifford R Jack; David Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2014-05-02       Impact factor: 9.910

2.  Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease.

Authors:  K A Jobst; A D Smith; C S Barker; A Wear; E M King; A Smith; P A Anslow; A J Molyneux; B J Shepstone; N Soper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Assessment of functional development in normal infant brain using arterial spin labeled perfusion MRI.

Authors:  Ze Wang; María Fernández-Seara; David C Alsop; Wen-Ching Liu; Judy F Flax; April A Benasich; John A Detre
Journal:  Neuroimage       Date:  2007-10-05       Impact factor: 6.556

4.  Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus.

Authors:  E Tedeschi; S G Hasselbalch; G Waldemar; M Juhler; P Høgh; S Holm; L Garde; L L Knudsen; L Klinken; F Gjerris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

5.  Exploring a mathematical model for the kinetics of beta-amyloid molecular imaging probes through a critical analysis of plaque pathology.

Authors:  Kooresh Shoghi-Jadid; Jorge R Barrio; Vladimir Kepe; Sung-Cheng Huang
Journal:  Mol Imaging Biol       Date:  2006 May-Jun       Impact factor: 3.488

6.  Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.

Authors:  L Arab; R Sadeghi; D G Walker; L-F Lue; M N Sabbagh
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.